Get started
Author

Yingying Yu

Direct targeting of SUZ12/ROCK2 by miR-200b/c inhibits cholangiocarcinoma tumourigenesis and metastasis
2013 · F Peng, J Jiang, et al. · British Journal of Cancer · 100
PDF
Biomarkers of myocardial injury in rats after cantharidin poisoning: Application for postmortem diagnosis and estimation of postmortem interval
2020 · Youyou Zhang, Yalei Yu, et al. · Scientific Reports · 10
PDF
MiR-888 promotes cell migration and invasion of hepatocellular carcinoma by targeting SMAD4.
2019 · Y-B Li, F-N Sun, et al. · PubMed · 8
Targeting high-risk MYC-overexpressed osteosarcoma with an Aurora kinase inhibitor:--results from a pilot umbrella trial
2025 · Kai Tian, Yafei Jiang, et al. · npj Precision Oncology · 3
PDF
Molecular Differences in Pancreatic Ductal Adenocarcinomas from Black versus White Patients
2024 · Saurabh Mandal, Emily A. Teslow, et al. · Cancer Research Communications · 3
PDF
Hepatic glutathione depletion ameliorates MASLD through selective protein oxidation and inhibition of lipogenesis
2026 · Xiang-Yu Liu, Guoxiao Wang, et al. · Journal of Clinical Investigation · 2
[The level of expression of adhesion molecules CD44v6 and E-cadherin in colorectal cancer and analysis of correlates with metastasis].
1999 · J Gu, X Zhu, et al. · PubMed · 2
KMT2C mutation to identify an immunotherapy-sensitive subset of gastrointestinal cancers: A large real-world analysis.
2026 · Bruno Bockorny, Brooke Rhead, et al. · Journal of Clinical Oncology · 1
Molecular and immune correlates of lymphocyte activation gene-3 expression in renal cell carcinoma
2026 · Harshitha Dudipala, Adam J Dugan, et al. · The Oncologist
PDF
Additional file 1 of Serum carotenoids modify the association between porphyromonas gingivalis IgG and mortality: a prospective cohort study with 25.8 years of follow-up
2026 · Weihong Qiu, Lijun Zheng, et al. · Figshare
Elevated IL-17A level is associated with poor overall survival following immune checkpoint inhibitors combined with targeted therapy in hepatocellular carcinoma with hyperbilirubinemia
2026 · Jianing Wang, Shida Pan, et al. · Frontiers in Immunology
PDF
Abstract 6507: Genomic characterization of lung cancer: ERRFI1 and NKX2-1 mutations and CLU expression
2026 · Metamia Ciampricotti, Yingying Yu, et al. · Cancer Research
Abstract 3990: Real-world evidence of KMT2C mutation as a biomarker of sensitivity to platinum-based therapy in solid cancers
2026 · Bruno Bockorny, Yingying Yu, et al. · Cancer Research
Molecular characteristics and clinical outcomes of patients with gastroesophageal cancer diagnosed at ages younger than 50 years
2026 · Michael H Storandt, Emily A Teslow, et al. · JNCI Cancer Spectrum
Genomic profiling of epithelial neoplasms of the appendix: Insights across histological subtypes and histological grades.
2026 · Michael J. Overman, Yingying Yu, et al. · Journal of Clinical Oncology
PDF
Distinct and convergent effects of SF3B1 mutations in human breast cancer
2025 · Riley E. Bergman, Christin I. Keeton, et al. · Proceedings of the National Academy of Sciences
PDF
Supplementary Table S5 from Molecular Differences in Pancreatic Ductal Adenocarcinomas from Black versus White Patients
2025 · Saurabh Mandal, Emily A. Teslow, et al.
Supplementary Table S2 from Molecular Differences in Pancreatic Ductal Adenocarcinomas from Black versus White Patients
2025 · Saurabh Mandal, Emily A. Teslow, et al.
Supplementary Table S4 from Molecular Differences in Pancreatic Ductal Adenocarcinomas from Black versus White Patients
2025 · Saurabh Mandal, Emily A. Teslow, et al.
Supplementary Table S1 from Molecular Differences in Pancreatic Ductal Adenocarcinomas from Black versus White Patients
2025 · Saurabh Mandal, Emily A. Teslow, et al.
Supplementary Table S3 from Molecular Differences in Pancreatic Ductal Adenocarcinomas from Black versus White Patients
2025 · Saurabh Mandal, Emily A. Teslow, et al.
Abstract 1157: Investigating the clinical landscape and biological impact of SF3B1 hotspot mutations in breast cancer
2025 · Riley Bergman, Tina M. O'Grady, et al. · Cancer Research
Molecular characteristics of early-onset versus average-onset gastroesophageal adenocarcinoma.
2025 · Amit Mahipal, Emily Teslow, et al. · Journal of Clinical Oncology
PDF
Data from Molecular Differences in Pancreatic Ductal Adenocarcinomas from Black versus White Patients
2025 · Saurabh Mandal, Emily A. Teslow, et al.
Table 1 from Molecular Differences in Pancreatic Ductal Adenocarcinomas from Black versus White Patients
2025 · Saurabh Mandal, Emily A. Teslow, et al.
Works count: 36
Citation count: 129
H-index: 3
I10-index: 2
Year
Topic
Type